Aysun Adan

3.2k total citations · 3 hit papers
34 papers, 2.4k citations indexed

About

Aysun Adan is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Aysun Adan has authored 34 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Hematology and 8 papers in Genetics. Recurrent topics in Aysun Adan's work include Sphingolipid Metabolism and Signaling (11 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Aysun Adan is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Aysun Adan collaborates with scholars based in Türkiye and Spain. Aysun Adan's co-authors include Yusuf Baran, Yağmur Kiraz, Melis Kartal Yandım, Ayten Nalbant, Müşerref Duygu Saçar Demirci, Elif Apohan, Alper Arslanoğlu, Ahmet Yemenicioğlu, Levent Yurdaer Aydemir and İlknur Kozanoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Hydrocolloids and Current Medicinal Chemistry.

In The Last Decade

Aysun Adan

33 papers receiving 2.3k citations

Hit Papers

Flow cytometry: basic principles and applications 2016 2026 2019 2022 2016 2016 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aysun Adan Türkiye 16 1.3k 352 302 292 228 34 2.4k
Arvindhan Nagarajan United States 19 1.2k 1.0× 245 0.7× 394 1.3× 230 0.8× 209 0.9× 40 2.5k
Xinyue Wang China 29 1.6k 1.2× 434 1.2× 208 0.7× 292 1.0× 299 1.3× 172 3.2k
Xiaowei Ma China 27 1.2k 1.0× 607 1.7× 229 0.8× 182 0.6× 219 1.0× 104 2.6k
Li Xiao China 32 1.2k 0.9× 437 1.2× 294 1.0× 345 1.2× 380 1.7× 163 3.0k
Santosh Kumar Singh India 17 1.4k 1.1× 320 0.9× 509 1.7× 463 1.6× 295 1.3× 84 2.8k
Nicholas Ekow Thomford South Africa 21 984 0.8× 354 1.0× 300 1.0× 465 1.6× 188 0.8× 45 2.6k
Francesca Sisto Italy 29 1.3k 1.0× 245 0.7× 646 2.1× 327 1.1× 189 0.8× 71 2.7k
Tingting Xu China 33 1.7k 1.3× 368 1.0× 599 2.0× 345 1.2× 292 1.3× 143 3.2k
Hongyi Li China 21 1.6k 1.3× 231 0.7× 400 1.3× 283 1.0× 316 1.4× 77 2.8k
Liang Wu China 27 1.1k 0.9× 341 1.0× 244 0.8× 147 0.5× 187 0.8× 109 2.0k

Countries citing papers authored by Aysun Adan

Since Specialization
Citations

This map shows the geographic impact of Aysun Adan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aysun Adan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aysun Adan more than expected).

Fields of papers citing papers by Aysun Adan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aysun Adan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aysun Adan. The network helps show where Aysun Adan may publish in the future.

Co-authorship network of co-authors of Aysun Adan

This figure shows the co-authorship network connecting the top 25 collaborators of Aysun Adan. A scholar is included among the top collaborators of Aysun Adan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aysun Adan. Aysun Adan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Adan, Aysun, et al.. (2024). Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current Treatment Options in Oncology. 25(6). 719–751. 5 indexed citations
3.
Adan, Aysun, et al.. (2022). Combined effect of midostaurin and sphingosine kinase-1 inhibitor on FMS-like tyrosine kinase 3 (FLT3) wild type acute myeloid leukemia cells. SHILAP Revista de lepidopterología. 47(1). 49–58. 3 indexed citations
6.
Adan, Aysun, et al.. (2022). Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches. OncoTargets and Therapy. Volume 15. 1449–1478. 25 indexed citations
7.
Adan, Aysun, et al.. (2021). Involvement of Sphingolipid Metabolism Enzymes in Resveratrol-Mediated Cytotoxicity in Philadelphia-Positive Acute Lymphoblastic Leukemia. Nutrition and Cancer. 74(7). 2508–2521. 7 indexed citations
8.
Kurt, Gökmen, et al.. (2018). A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study. TURKISH JOURNAL OF BIOLOGY. 42(5). 382–391. 3 indexed citations
9.
Kurt, Gökmen, Yusuf Baran, Volkan Seyrantepe, et al.. (2016). Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth. European Journal of Orthodontics. 39(3). cjw054–cjw054. 14 indexed citations
10.
Adan, Aysun, Yağmur Kiraz, & Yusuf Baran. (2016). Cell Proliferation and Cytotoxicity Assays. Current Pharmaceutical Biotechnology. 17(14). 1213–1221. 389 indexed citations breakdown →
11.
Kiraz, Yağmur, Aysun Adan, Melis Kartal Yandım, & Yusuf Baran. (2016). Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology. 37(7). 8471–8486. 464 indexed citations breakdown →
12.
Karaman, Meral, Aysun Adan, Müge Kıray, et al.. (2016). Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model. European Archives of Oto-Rhino-Laryngology. 274(1). 197–207. 17 indexed citations
13.
Adan, Aysun, et al.. (2016). Flow cytometry: basic principles and applications. Critical Reviews in Biotechnology. 37(2). 163–176. 598 indexed citations breakdown →
15.
Adan, Aysun, et al.. (2015). A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells. SHILAP Revista de lepidopterología. 32(2). 118–126. 2 indexed citations
17.
Adan, Aysun, Hakan Özdoğu, Can Boğa, et al.. (2014). Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells. Nutrition and Cancer. 66(4). 599–612. 26 indexed citations
18.
Sevindik, Ömür Gökmen, Aysun Adan, Güner Hayri Özsan, et al.. (2014). Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion. Clinical and Applied Thrombosis/Hemostasis. 21(7). 678–683. 8 indexed citations
19.
Adan, Aysun, Çığır Biray Avcı, Buket Kosova, et al.. (2013). STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells. Biomedicine & Pharmacotherapy. 67(6). 527–532. 11 indexed citations
20.
Bernal, Sara, et al.. (2001). Evaluation of RLBP1 in 50 autosomal recessive retinitis pigmentosa and 4 retinitis punctata albescens Spanish families. Ophthalmic Genetics. 22(1). 19–25. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026